Modification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.08.2026. Verfasst von Kaikai Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Materials Science, Jiangsu Key Laboratory of Bio-functional Materials, Jiangsu Collaborative Innovation Centre of Biomedical…. Hauptthemen laut MEDLINE: Succinate Dehydrogenase, Mitochondria, Urinary Bladder Neoplasms, Enzyme Inhibitors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Succinate dehydrogenase (SDH, complex II) connects the tricarboxylic acid (TCA) cycle to the electron transport chain (ETC), maintaining mitochondrial energy homeostasis. Selective SDH inhibition in diseased tissue has remained challenging due to the highly conserved catalytic architecture across normal tissues. Here, we reveal that SDH catalytic activity depends on the acetylation state of its catalytic subunit A (SDHA): the non‐acetylated form is catalytically active but exhibits fragile homeostasis in bladder cancer, contrasting with its robust maintenance in normal cells. Guided by this insight, we designed ZPI‐3, a conformationally optimized inhibitor that selectively engages the non‐acetylated SDHA, suppressing tumor SDH activity and growth while sparing normal cells. In orthotopic NMIBC models, ZPI‐3 outperforms mitomycin‐C. Differential SDH responses to ZPI‐3 in clinical specimens further suggest its potential for patient stratification and precision therapy. These findings establish modification‐selective inhibition as a paradigm for tumor‐selective mitochondrial modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Materials Science, Jiangsu Key Laboratory of Bio-functional Materials, Jiangsu Collaborative Innovation Centre of Biomedical Functional Materials, Nanjing Normal University, Nanjing, China.
- School of Science, Key Laboratory of High Performance Scientific Computation, Xihua University, Chengdu, China.
- Department of Urology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Institute of Urology, Nanjing University, Nanjing, China.
- School of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, China.
ORCID-Profile: Ning Wang, Yongming Deng, Lin Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, K., Kong, L., Ye, K., Bao, X., Liu, H., Wang, N., Deng, Y., Wang, W., Wei, S., & Zhou, L. (2026). Modification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation. Advanced Science, 13(62). https://doi.org/10.1002/advs.77046
Vancouver
Xu K, Kong L, Ye K, Bao X, Liu H, Wang N, et al. Modification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation. Advanced Science. 2026;13(62). doi:10.1002/advs.77046
BibTeX
@article{Xu2026,
author = {Xu, Kaikai and Kong, Lulu and Ye, Kebin and Bao, Xinlu and Liu, Haowen and Wang, Ning and Deng, Yongming and Wang, Wei and Wei, Shaohua and Zhou, Lin},
title = {Modification‐Selective Inhibition of Succinate Dehydrogenase a Enables Tumor‐Restricted Mitochondrial Modulation},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77046}
}
EUVIMED